- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07736417
Effects of Core Stabilization Exercises on Postural Control in Spastic Diplegic CP Children
August 30, 2026 updated by: Shafaq Altaf, Shifa Tameer-e-Millat University
Effects of Core Stabilization Exercises on Postural Control in Spastic Diplegic CP Children: a Randomized Control Trial
This randomized controlled trial will evaluate the effectiveness of a 12-week comprehensive core stabilization exercise program on balance, trunk control, and gross motor function in children with spastic diplegic cerebral palsy.
Outcome measures will be assessed at baseline and at the end of the intervention to determine changes following treatment.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Islamabad, Pakistan
- Shifa Tameer-e-Millat University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Children diagnosed with spastic diplegic cerebral palsy
- Gross Motor Function Classification System (GMFCS) Levels II-III
- Stable medical management for at least 3 months prior to enrollment
- Ability to understand and follow simple verbal instructions
Exclusion Criteria:
- Fixed contracture or musculoskeletal deformities limiting exercise
- Orthopedic surgery or botulinum injection within the previous 3 months
- Uncontrolled epilepsy
- Severe visual impairment
- Participation in another rehabilitation intervention during the study period
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Core Stabilization Exercise Program with Conventional Therapy
Participants will receive a structured core stabilization exercise program in addition to conventional physiotherapy.
The program includes progressive exercises targeting trunk muscle activation, trunk control, and postural control, tailored to each participant's functional ability.
Sessions will be conducted 3 times per week for 12 weeks.
|
Progressive exercises targeting trunk muscle strength, stability, and postural control alongside conventional therapy
Stretching exercises, strengthening exercises, balance training, gait training, functional activities according to standard rehabilitation practice
|
|
Active Comparator: Conventional therapy
Participants will receive conventional physiotherapy consisting of stretching, strengthening, balance training, gait training, and functional exercises according to standard rehabilitation practice.
Sessions will be conducted 3 times per week for 12 weeks.
|
Stretching exercises, strengthening exercises, balance training, gait training, functional activities according to standard rehabilitation practice
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Balance
Time Frame: Baseline and post 12 weeks of intervention
|
Pediatric Balance Scale (PBS) is a 14-item performance-based scale used to assess functional balance in children.
Total scores range from 0 to 56, with higher scores indicating better balance.
|
Baseline and post 12 weeks of intervention
|
|
Trunk Control
Time Frame: Baseline and post 12 weeks of intervention
|
Trunk Control Measurement Scale (TCMS) is a clinical scale used to evaluate static and dynamic trunk control and trunk coordination in children with cerebral palsy.
Total scores range from 0 to 58, with higher scores indicating better trunk control.
|
Baseline and post 12 weeks of intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gross Motor Function
Time Frame: Baseline and post 12 weeks of intervention
|
Gross Motor Function Measure (GMFM-88) is a standardized observational measure used to assess gross motor function in children with cerebral palsy across activities such as lying, sitting, crawling, standing, and walking.
Scores range from 0 to 100%, with higher scores indicating better gross motor function.
|
Baseline and post 12 weeks of intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
November 1, 2026
Study Registration Dates
First Submitted
July 25, 2026
First Submitted That Met QC Criteria
July 25, 2026
First Posted (Actual)
July 30, 2026
Study Record Updates
Last Update Posted (Actual)
September 1, 2026
Last Update Submitted That Met QC Criteria
August 30, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Brain Damage, Chronic
- Cerebral Palsy
- Motor Activity
- Movement
- Musculoskeletal Physiological Phenomena
- Musculoskeletal and Neural Physiological Phenomena
- Organizations
- Health Care Economics and Organizations
- Exercise
- Congresses as Topic
Other Study ID Numbers
- 064-26
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.